Report Detail

Pharma & Healthcare Global Celiac Drugs Sales Market Report 2021

  • RnM3760032
  • |
  • 01 June, 2021
  • |
  • Global
  • |
  • 150 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

The global Celiac Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Celiac Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type
First Line Of Treatment
Second Line Of Treatment

Segment by Application
Men
Women
Children

The Celiac Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Celiac Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company
ADMA Biologics
Amgen
Anthera Pharmaceuticals
Bayer
Biogen
BioLineRx
Biotest
Bristol-Myers Squibb
Celgene
Celimmune
F Hoffmann-La Roche
ImmunogenX
Immunomedics
ImmusanT
Innovate Biopharmaceuticals
Johnson & Johnson
Kedrion Biopharma
LFB Group
Merck
Novartis


1 Celiac Drugs Market Overview

  • 1.1 Celiac Drugs Product Scope
  • 1.2 Celiac Drugs Segment by Type
    • 1.2.1 Global Celiac Drugs Sales by Type (2016 & 2021 & 2027)
    • 1.2.2 First Line Of Treatment
    • 1.2.3 Second Line Of Treatment
  • 1.3 Celiac Drugs Segment by Application
    • 1.3.1 Global Celiac Drugs Sales Comparison by Application (2016 & 2021 & 2027)
    • 1.3.2 Men
    • 1.3.3 Women
    • 1.3.4 Children
  • 1.4 Celiac Drugs Market Estimates and Forecasts (2016-2027)
    • 1.4.1 Global Celiac Drugs Market Size in Value Growth Rate (2016-2027)
    • 1.4.2 Global Celiac Drugs Market Size in Volume Growth Rate (2016-2027)
    • 1.4.3 Global Celiac Drugs Price Trends (2016-2027)

2 Celiac Drugs Estimates and Forecasts by Region

  • 2.1 Global Celiac Drugs Market Size by Region: 2016 VS 2021 VS 2027
  • 2.2 Global Celiac Drugs Retrospective Market Scenario by Region (2016-2021)
    • 2.2.1 Global Celiac Drugs Sales Market Share by Region (2016-2021)
    • 2.2.2 Global Celiac Drugs Revenue Market Share by Region (2016-2021)
  • 2.3 Global Celiac Drugs Market Estimates and Forecasts by Region (2022-2027)
    • 2.3.1 Global Celiac Drugs Sales Estimates and Forecasts by Region (2022-2027)
    • 2.3.2 Global Celiac Drugs Revenue Forecast by Region (2022-2027)
  • 2.4 Geographic Market Analysis: Market Facts & Figures
    • 2.4.1 North America Celiac Drugs Estimates and Projections (2016-2027)
    • 2.4.2 Europe Celiac Drugs Estimates and Projections (2016-2027)
    • 2.4.3 China Celiac Drugs Estimates and Projections (2016-2027)
    • 2.4.4 Japan Celiac Drugs Estimates and Projections (2016-2027)
    • 2.4.5 Southeast Asia Celiac Drugs Estimates and Projections (2016-2027)
    • 2.4.6 India Celiac Drugs Estimates and Projections (2016-2027)

3 Global Celiac Drugs Competition Landscape by Players

  • 3.1 Global Top Celiac Drugs Players by Sales (2016-2021)
  • 3.2 Global Top Celiac Drugs Players by Revenue (2016-2021)
  • 3.3 Global Celiac Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Celiac Drugs as of 2020)
  • 3.4 Global Celiac Drugs Average Price by Company (2016-2021)
  • 3.5 Manufacturers Celiac Drugs Manufacturing Sites, Area Served, Product Type
  • 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Celiac Drugs Market Size by Type

  • 4.1 Global Celiac Drugs Historic Market Review by Type (2016-2021)
    • 4.1.1 Global Celiac Drugs Sales Market Share by Type (2016-2021)
    • 4.1.2 Global Celiac Drugs Revenue Market Share by Type (2016-2021)
    • 4.1.3 Global Celiac Drugs Price by Type (2016-2021)
  • 4.2 Global Celiac Drugs Market Estimates and Forecasts by Type (2022-2027)
    • 4.2.1 Global Celiac Drugs Sales Forecast by Type (2022-2027)
    • 4.2.2 Global Celiac Drugs Revenue Forecast by Type (2022-2027)
    • 4.2.3 Global Celiac Drugs Price Forecast by Type (2022-2027)

5 Global Celiac Drugs Market Size by Application

  • 5.1 Global Celiac Drugs Historic Market Review by Application (2016-2021)
    • 5.1.1 Global Celiac Drugs Sales Market Share by Application (2016-2021)
    • 5.1.2 Global Celiac Drugs Revenue Market Share by Application (2016-2021)
    • 5.1.3 Global Celiac Drugs Price by Application (2016-2021)
  • 5.2 Global Celiac Drugs Market Estimates and Forecasts by Application (2022-2027)
    • 5.2.1 Global Celiac Drugs Sales Forecast by Application (2022-2027)
    • 5.2.2 Global Celiac Drugs Revenue Forecast by Application (2022-2027)
    • 5.2.3 Global Celiac Drugs Price Forecast by Application (2022-2027)

6 North America Celiac Drugs Market Facts & Figures

  • 6.1 North America Celiac Drugs Sales by Company
    • 6.1.1 North America Celiac Drugs Sales by Company (2016-2021)
    • 6.1.2 North America Celiac Drugs Revenue by Company (2016-2021)
  • 6.2 North America Celiac Drugs Sales Breakdown by Type
    • 6.2.1 North America Celiac Drugs Sales Breakdown by Type (2016-2021)
    • 6.2.2 North America Celiac Drugs Sales Breakdown by Type (2022-2027)
  • 6.3 North America Celiac Drugs Sales Breakdown by Application
    • 6.3.1 North America Celiac Drugs Sales Breakdown by Application (2016-2021)
    • 6.3.2 North America Celiac Drugs Sales Breakdown by Application (2022-2027)

7 Europe Celiac Drugs Market Facts & Figures

  • 7.1 Europe Celiac Drugs Sales by Company
    • 7.1.1 Europe Celiac Drugs Sales by Company (2016-2021)
    • 7.1.2 Europe Celiac Drugs Revenue by Company (2016-2021)
  • 7.2 Europe Celiac Drugs Sales Breakdown by Type
    • 7.2.1 Europe Celiac Drugs Sales Breakdown by Type (2016-2021)
    • 7.2.2 Europe Celiac Drugs Sales Breakdown by Type (2022-2027)
  • 7.3 Europe Celiac Drugs Sales Breakdown by Application
    • 7.3.1 Europe 150 Sales Breakdown by Application (2016-2021)
    • 7.3.2 Europe 150 Sales Breakdown by Application (2022-2027)

8 China Celiac Drugs Market Facts & Figures

  • 8.1 China Celiac Drugs Sales by Company
    • 8.1.1 China Celiac Drugs Sales by Company (2016-2021)
    • 8.1.2 China Celiac Drugs Revenue by Company (2016-2021)
  • 8.2 China Celiac Drugs Sales Breakdown by Type
    • 8.2.1 China Celiac Drugs Sales Breakdown by Type (2016-2021)
    • 8.2.2 China Celiac Drugs Sales Breakdown by Type (2022-2027)
  • 8.3 China Celiac Drugs Sales Breakdown by Application
    • 8.3.1 China 174 Sales Breakdown by Application (2016-2021)
    • 8.3.2 China 174 Sales Breakdown by Application (2022-2027)

9 Japan Celiac Drugs Market Facts & Figures

  • 9.1 Japan Celiac Drugs Sales by Company
    • 9.1.1 Japan Celiac Drugs Sales by Company (2016-2021)
    • 9.1.2 Japan Celiac Drugs Revenue by Company (2016-2021)
  • 9.2 Japan Celiac Drugs Sales Breakdown by Type
    • 9.2.1 Japan Celiac Drugs Sales Breakdown by Type (2016-2021)
    • 9.2.2 Japan Celiac Drugs Sales Breakdown by Type (2022-2027)
  • 9.3 Japan Celiac Drugs Sales Breakdown by Application
    • 9.3.1 Japan Mar. Sales Breakdown by Application (2016-2021)
    • 9.3.2 Japan Mar. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Celiac Drugs Market Facts & Figures

  • 10.1 Southeast Asia Celiac Drugs Sales by Company
    • 10.1.1 Southeast Asia Celiac Drugs Sales by Company (2016-2021)
    • 10.1.2 Southeast Asia Celiac Drugs Revenue by Company (2016-2021)
  • 10.2 Southeast Asia Celiac Drugs Sales Breakdown by Type
    • 10.2.1 Southeast Asia Celiac Drugs Sales Breakdown by Type (2016-2021)
    • 10.2.2 Southeast Asia Celiac Drugs Sales Breakdown by Type (2022-2027)
  • 10.3 Southeast Asia Celiac Drugs Sales Breakdown by Application
    • 10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
    • 10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)

11 India Celiac Drugs Market Facts & Figures

  • 11.1 India Celiac Drugs Sales by Company
    • 11.1.1 India Celiac Drugs Sales by Company (2016-2021)
    • 11.1.2 India Celiac Drugs Revenue by Company (2016-2021)
  • 11.2 India Celiac Drugs Sales Breakdown by Type
    • 11.2.1 India Celiac Drugs Sales Breakdown by Type (2016-2021)
    • 11.2.2 India Celiac Drugs Sales Breakdown by Type (2022-2027)
  • 11.3 India Celiac Drugs Sales Breakdown by Application
    • 11.3.1 India Celiac Drugs Sales Breakdown by Application (2016-2021)
    • 11.3.2 India Celiac Drugs Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Celiac Drugs Business

  • 12.1 ADMA Biologics
    • 12.1.1 ADMA Biologics Corporation Information
    • 12.1.2 ADMA Biologics Business Overview
    • 12.1.3 ADMA Biologics Celiac Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.1.4 ADMA Biologics Celiac Drugs Products Offered
    • 12.1.5 ADMA Biologics Recent Development
  • 12.2 Amgen
    • 12.2.1 Amgen Corporation Information
    • 12.2.2 Amgen Business Overview
    • 12.2.3 Amgen Celiac Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.2.4 Amgen Celiac Drugs Products Offered
    • 12.2.5 Amgen Recent Development
  • 12.3 Anthera Pharmaceuticals
    • 12.3.1 Anthera Pharmaceuticals Corporation Information
    • 12.3.2 Anthera Pharmaceuticals Business Overview
    • 12.3.3 Anthera Pharmaceuticals Celiac Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.3.4 Anthera Pharmaceuticals Celiac Drugs Products Offered
    • 12.3.5 Anthera Pharmaceuticals Recent Development
  • 12.4 Bayer
    • 12.4.1 Bayer Corporation Information
    • 12.4.2 Bayer Business Overview
    • 12.4.3 Bayer Celiac Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.4.4 Bayer Celiac Drugs Products Offered
    • 12.4.5 Bayer Recent Development
  • 12.5 Biogen
    • 12.5.1 Biogen Corporation Information
    • 12.5.2 Biogen Business Overview
    • 12.5.3 Biogen Celiac Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.5.4 Biogen Celiac Drugs Products Offered
    • 12.5.5 Biogen Recent Development
  • 12.6 BioLineRx
    • 12.6.1 BioLineRx Corporation Information
    • 12.6.2 BioLineRx Business Overview
    • 12.6.3 BioLineRx Celiac Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.6.4 BioLineRx Celiac Drugs Products Offered
    • 12.6.5 BioLineRx Recent Development
  • 12.7 Biotest
    • 12.7.1 Biotest Corporation Information
    • 12.7.2 Biotest Business Overview
    • 12.7.3 Biotest Celiac Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.7.4 Biotest Celiac Drugs Products Offered
    • 12.7.5 Biotest Recent Development
  • 12.8 Bristol-Myers Squibb
    • 12.8.1 Bristol-Myers Squibb Corporation Information
    • 12.8.2 Bristol-Myers Squibb Business Overview
    • 12.8.3 Bristol-Myers Squibb Celiac Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.8.4 Bristol-Myers Squibb Celiac Drugs Products Offered
    • 12.8.5 Bristol-Myers Squibb Recent Development
  • 12.9 Celgene
    • 12.9.1 Celgene Corporation Information
    • 12.9.2 Celgene Business Overview
    • 12.9.3 Celgene Celiac Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.9.4 Celgene Celiac Drugs Products Offered
    • 12.9.5 Celgene Recent Development
  • 12.10 Celimmune
    • 12.10.1 Celimmune Corporation Information
    • 12.10.2 Celimmune Business Overview
    • 12.10.3 Celimmune Celiac Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.10.4 Celimmune Celiac Drugs Products Offered
    • 12.10.5 Celimmune Recent Development
  • 12.11 F Hoffmann-La Roche
    • 12.11.1 F Hoffmann-La Roche Corporation Information
    • 12.11.2 F Hoffmann-La Roche Business Overview
    • 12.11.3 F Hoffmann-La Roche Celiac Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.11.4 F Hoffmann-La Roche Celiac Drugs Products Offered
    • 12.11.5 F Hoffmann-La Roche Recent Development
  • 12.12 ImmunogenX
    • 12.12.1 ImmunogenX Corporation Information
    • 12.12.2 ImmunogenX Business Overview
    • 12.12.3 ImmunogenX Celiac Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.12.4 ImmunogenX Celiac Drugs Products Offered
    • 12.12.5 ImmunogenX Recent Development
  • 12.13 Immunomedics
    • 12.13.1 Immunomedics Corporation Information
    • 12.13.2 Immunomedics Business Overview
    • 12.13.3 Immunomedics Celiac Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.13.4 Immunomedics Celiac Drugs Products Offered
    • 12.13.5 Immunomedics Recent Development
  • 12.14 ImmusanT
    • 12.14.1 ImmusanT Corporation Information
    • 12.14.2 ImmusanT Business Overview
    • 12.14.3 ImmusanT Celiac Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.14.4 ImmusanT Celiac Drugs Products Offered
    • 12.14.5 ImmusanT Recent Development
  • 12.15 Innovate Biopharmaceuticals
    • 12.15.1 Innovate Biopharmaceuticals Corporation Information
    • 12.15.2 Innovate Biopharmaceuticals Business Overview
    • 12.15.3 Innovate Biopharmaceuticals Celiac Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.15.4 Innovate Biopharmaceuticals Celiac Drugs Products Offered
    • 12.15.5 Innovate Biopharmaceuticals Recent Development
  • 12.16 Johnson & Johnson
    • 12.16.1 Johnson & Johnson Corporation Information
    • 12.16.2 Johnson & Johnson Business Overview
    • 12.16.3 Johnson & Johnson Celiac Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.16.4 Johnson & Johnson Celiac Drugs Products Offered
    • 12.16.5 Johnson & Johnson Recent Development
  • 12.17 Kedrion Biopharma
    • 12.17.1 Kedrion Biopharma Corporation Information
    • 12.17.2 Kedrion Biopharma Business Overview
    • 12.17.3 Kedrion Biopharma Celiac Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.17.4 Kedrion Biopharma Celiac Drugs Products Offered
    • 12.17.5 Kedrion Biopharma Recent Development
  • 12.18 LFB Group
    • 12.18.1 LFB Group Corporation Information
    • 12.18.2 LFB Group Business Overview
    • 12.18.3 LFB Group Celiac Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.18.4 LFB Group Celiac Drugs Products Offered
    • 12.18.5 LFB Group Recent Development
  • 12.19 Merck
    • 12.19.1 Merck Corporation Information
    • 12.19.2 Merck Business Overview
    • 12.19.3 Merck Celiac Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.19.4 Merck Celiac Drugs Products Offered
    • 12.19.5 Merck Recent Development
  • 12.20 Novartis
    • 12.20.1 Novartis Corporation Information
    • 12.20.2 Novartis Business Overview
    • 12.20.3 Novartis Celiac Drugs Sales, Revenue and Gross Margin (2016-2021)
    • 12.20.4 Novartis Celiac Drugs Products Offered
    • 12.20.5 Novartis Recent Development

13 Celiac Drugs Manufacturing Cost Analysis

  • 13.1 Celiac Drugs Key Raw Materials Analysis
    • 13.1.1 Key Raw Materials
    • 13.1.2 Key Raw Materials Price Trend
    • 13.1.3 Key Suppliers of Raw Materials
  • 13.2 Proportion of Manufacturing Cost Structure
  • 13.3 Manufacturing Process Analysis of Celiac Drugs
  • 13.4 Celiac Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

  • 14.1 Marketing Channel
  • 14.2 Celiac Drugs Distributors List
  • 14.3 Celiac Drugs Customers

15 Market Dynamics

  • 15.1 Celiac Drugs Market Trends
  • 15.2 Celiac Drugs Drivers
  • 15.3 Celiac Drugs Market Challenges
  • 15.4 Celiac Drugs Market Restraints

16 Research Findings and Conclusion

    17 Appendix

    • 17.1 Research Methodology
      • 17.1.1 Methodology/Research Approach
      • 17.1.2 Data Source
    • 17.2 Author List

    Summary:
    Get latest Market Research Reports on Celiac Drugs . Industry analysis & Market Report on Celiac Drugs is a syndicated market report, published as Global Celiac Drugs Sales Market Report 2021. It is complete Research Study and Industry Analysis of Celiac Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,000.00
    $6,000.00
    $8,000.00
    3,152.00
    4,728.00
    6,304.00
    3,680.00
    5,520.00
    7,360.00
    622,480.00
    933,720.00
    1,244,960.00
    333,520.00
    500,280.00
    667,040.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report